Equity Factor Research

Low Volatility

Low-risk stocks earn as much or more than high-risk ones — the anomaly that most directly contradicts the CAPM, hiding in a noisy, over-tagged corner of the corpus.

Momentum

Past winners keep winning over 3–12 month horizons — one of finance's most robust anomalies, and one of its most crash-prone.

Quality

Profitable, well-run, conservatively-financed firms beat junk — the best-curated topic in the library, and the value investor's essential complement.

Reversal

Losers bounce back — over days (liquidity provision) and over years (overreaction). Two distinct effects often confused under one name.

Size

Small stocks once beat large — the premium that launched factor investing, then largely vanished, and now survives mainly as a conditioning variable.

The Factor Zoo & Replication Crisis

Hundreds of published factors, most of them fragile — the meta-literature on multiple testing, post-publication decay, and what actually survives. This is the lens the whole platform is built around.

Value

Cheap stocks beat expensive ones over the long run — the oldest cross-sectional premium, and the one whose recent decade-long drawdown has most tested investors' faith.

Stocks that have risen keep rising — for a while.

Markets underreact to earnings news. Drift persists for months.

Cheap stocks outperform expensive ones — on average, over long horizons.

High-yield assets outperform low-yield assets across almost every market.

Profitable, conservatively financed firms earn persistently higher returns.

Boring stocks win. The high-volatility premium is inverted.

Small-cap stocks earn a premium — but it has nearly vanished.

Illiquid stocks earn a premium for being hard to trade.

With 400+ published factors, most are likely false discoveries.